Biosensors International Group Email Formats

Medical Equipment Manufacturing • Boon Lay, West Region, Singapore • 201-500 Employees

Biosensors International Group Email Formats

Biosensors International Group uses 5 email formats. The most common is {first initial}.{last name} (e.g., j.doe@biosensors.com), used 42.2% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@biosensors.com	44.9%
{first name}.{last name}	john.doe@biosensors.com	49.6%
{last name}.{last name}	doe.doe@biosensors.com	3.4%

Key Contacts at Biosensors International Group

Ryan Tee

Senior Director, Qara

Orlando Antunes

Regulatory Affairs Director Emea Prrc

Ignacio Martínez Arbués

Director, Iberia Switzerland And Benelux

Todd Stephens

Marketing Director Biosensors International - Emea & Americas

Lars Arnold

Director Of Structural Heart, Clinical Specialist & Training Support. Emea

Russ Hughes

Director Of Sales, Uk & Ireland

Amy Xie

Associate Director Regulatory Affairs, Apac & Projects

Sandy Torres

Human Resources Director

Aurore Bouvier

Director, Business Development Emea & Americas

Maria Soldado

Associate Director Finance

Company overview

Headquarters	36, Jalan Tukang, Singapore, 619266, SG
Phone number	+6511181000
Website	biosensors.com
SIC	384
Keywords	Balloons, Structural Heart, Cardiology Medical Device, Stents, Tavi, Pioneering Technology
Founded	1990
Employees	201-500
Socials

About Biosensors International Group

Biosensors International develops, manufactures and markets pioneering interventional cardiology devices. The BioMatrix™ DES family features Biolimus A9™ (BA9™), a highly lipophilic anti-restenotic drug designed for cardiovascular stent technologies patented by Biosensors, combined in a unique abluminal biodegradable polymer coating. BioMatrix Alpha™, the latest addition to the family, is a CoCr stent featuring an innovative hybrid design, thin struts and an advanced delivery system. BioFreedom™ demonstrated superior safety and efficacy vs BMS in High Bleeding Risk patients in the landmark LEADERS FREE trial and features a selectively micro-structured abluminal surface allowing polymer & carrier free delivery of BA9™. Recently Biosensors’ parent company made a significant investment into the rapidly growing field of structural heart disease intervention through the acquisition of the company New Valve Technology (NVT), the developers of the flagship product Allegra™ transfemoral TAVI system. Together, Biosensors and NVT will leverage our their respective innovative expertise in Cardiovascular and Structural Heart technologies. Our aim is to improve patients’ lives through pioneering medical technology that pushes the boundaries of innovation. Through our high quality medical devices we impact the lives we touch and we are committed to continued investment in the development of pioneering medical technology, robust clinical data and engineering new medical devices that will further benefit your patients.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Manager

Director

Employees by Department

Biosensors International Group has 266 employees across 15 departments.

Departments

Number of employees

Funding Data

Explore Biosensors International Group's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2010-11-14	14	$219,100,000

Funding Insights

$219,100,000

Total funding amount

$219,100,000

Most recent funding amount

Number of funding rounds

Biosensors International Group Tech Stack

Discover the technologies and tools that power Biosensors International Group's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

JW Player

Video players

OpenSSL

Web server extensions

CentOS

Operating systems

Lightbox

JavaScript libraries

PHP

Programming languages

Google Tag Manager

Tag managers

Font Awesome

Font scripts

Drupal

CMS

Bootstrap

UI frameworks

Google Analytics

Analytics

Frequently asked questions

Biosensors International Group is located in Boon Lay, West Region, SG.

You can reach Biosensors International Group at +6511181000.

Biosensors International Group was founded in 1990, making it 36 years old. The company has established itself as a significant player in its industry over this time.

Biosensors International Group has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

Biosensors International Group has raised a total of $219,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.